Human cytomegalovirus, human herpesvirus-6 and human herpesvirus-7 in neutropenic patients with fever of unknown origin

被引:18
|
作者
Persson, L [1 ]
Dahl, H
Linde, A
Engervall, P
Vikerfors, T
Tidefelt, U
机构
[1] Orebro Univ Hosp, Dept Infect Dis, SE-70185 Orebro, Sweden
[2] Orebro Univ Hosp, Dept Internal Med, SE-70185 Orebro, Sweden
[3] Karolinska Inst, Swedish Inst Infect Control, Stockholm, Sweden
[4] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
[5] Karolinska Hosp, Dept Haematol, S-10401 Stockholm, Sweden
关键词
neutropenia; leukemia; fever; herpes DNA-emia; bacteremia;
D O I
10.1046/j.1469-0691.2003.00578.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective To investigate the appearance of cytomegalovirus (CMV) DNA, human herpesvirus-6 (HHV-6) DNA and human herpesvirus-7 (HHV-7) DNA in plasma as a sign of reactivation and possible causes of fever of unknown origin (FUO) during neutropenia. Methods From 134 patients with febrile neutropenia following cytotoxic chemotherapy during the years 1996-2000, 20 severely neutropenic patients (granulocyte count < 0.1 x 10(9) /L) were selected. Ten were patients with bacteremia and ten were patients with FUO. Five samples from each patient were selected at the start of chemotherapy, at the time of blood culture and fever, after 24 and 48 hours of fever, and, finally, after two to three days without fever. Virus DNA was detected by real-time quantitative and nested polymerase chain reaction (PCR). Results CMV-DNA was detected in two out of ten FUO-patients in all samples drawn during fever. From another FUO and during two bacteremia episodes, CMV-DNA was detected after 48 hours of fever. DNA from HHV-6 and HHV-7 was not detected in any of the 20 febrile episodes. Conclusions HHV-6 and HHV-7 as a possible explanation for FUO in severely neutropenic patients treated with cytotoxic chemotherapy seems not be very likely. However, CMV was identified in 5/20 patients and the febrile episodes in the two FUO-patients with constant DNA-emia may have been caused by a reactivation of CMV. This implies that CMV infection can be expected not only in transplant patients but also in chemotherapy-treated neutropenic patients.
引用
收藏
页码:640 / 644
页数:5
相关论文
共 17 条
  • [1] Human Endogenous Retrovirus-K18 Superantigen Expression and Human Herpesvirus-6 and Human Herpesvirus-7 Viral Loads in Chronic Fatigue Patients
    Oakes, Brendan
    Hoagland-Henefield, Matthias
    Komaroff, Anthony L.
    Erickson, Jessica L.
    Huber, Brigitte T.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (10) : 1394 - 1400
  • [2] Quantitative Analysis of Human Herpesvirus-6 and Human Cytomegalovirus in Blood and Saliva From Patients With Acute Leukemia
    Nefzi, Faten
    Ben Salem, Nabil Abid
    Khelif, Abderrahim
    Feki, Salma
    Aouni, Mahjoub
    Gautheret-Dejean, Agnes
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (03) : 451 - 460
  • [3] Human herpesvirus-6 circulation in healthy adults and oncologic patients
    Carricart, SE
    Bustos, DA
    Grutadauria, SL
    Nates, SV
    Garcia, JJ
    Yacci, MR
    Gendelman, H
    Pavan, JV
    MEDICINA-BUENOS AIRES, 2002, 62 (01) : 9 - 12
  • [4] Choreoathetosis in the Setting of Human Herpesvirus-6 Infection in a Transplant Recipient
    Mancone, Sarah
    Selvadurai, Chindhuri
    Baehring, Joachim
    Patel, Amar
    TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2021, 11
  • [5] Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection
    Chemaly, Roy F.
    Torres, Harrys A.
    Hachem, Ray
    Kontoyiannis, Dimitrios P.
    Safdar, Amar
    Raad, Issam I.
    HAEMATOLOGICA, 2007, 93 (01) : 157 - 158
  • [6] Presence of human herpesvirus type 6, polyoma BK virus and parvovirus B19V in non-transplanted patients with hematological malignancies and neutropenic fever
    Gustafsson, Igge
    Aust, Carl
    Yun, Zhibing
    Broliden, Kristina
    Ohrmalm, Lars
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (03):
  • [7] Quantitation of human herpesvirus-6 (HHV-6) DNA in a cord blood transplant recipient with chromosomal integration of HHV-6
    Kobayashi, D.
    Kogawa, K.
    Imai, K.
    Tanaka, T.
    Hiroi, S.
    Satoh, H.
    Tanaka-Taya, K.
    Nonoyama, S.
    TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (06) : 650 - 653
  • [8] Pyrexia in human herpesvirus 6 (HHV6)-infected patients: A systems virology study
    Chenari, Maryam
    Forghani-Ramandi, Mohammad-Moien
    Taherzadeh-Ghafarokhi, Nooshin
    Mokhtari-Azad, Talat
    Shadabi, Shahrzad
    Mozhgani, Sayed-Hamidreza
    Arjmand, Reza
    Mohammadhosayni, Mina
    Karami, Hassan
    Rezaei, Farhad
    GENE REPORTS, 2021, 23
  • [9] Increased seroprevalence of human herpesvirus 8 in patients with hematological disorders
    Tsai, WH
    Lee, YM
    Kuo, BIT
    Ho, CK
    Liao, PT
    Liu, MD
    Kou, YR
    Hsu, HC
    ACTA HAEMATOLOGICA, 2005, 114 (02) : 95 - 98
  • [10] Infections due to human herpesvirus 6 in solid organ transplant recipients
    Razonable, Raymund R.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (06) : 671 - 675